Targeting cardiac hypertrophy through a nuclear co‐repressor
Heart failure entails the inability of the heart to pump blood to vital organs. One of the main risk factors for heart failure is the development of pathological hypertrophy. In this issue of EMBO Molecular Medicine, Li and coworkers show that NCoR1, a co‐repressor of transcription factors, inhibits...
Main Authors: | Andrea Grund, Joerg Heineke |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-11-01
|
Series: | EMBO Molecular Medicine |
Online Access: | https://doi.org/10.15252/emmm.201911297 |
Similar Items
-
Nuclear receptor corepressor 1 represses cardiac hypertrophy
by: Chao Li, et al.
Published: (2019-11-01) -
The Nuclear Receptor—Co-repressor Complex in Control of Liver Metabolism and Disease
by: Ning Liang, et al.
Published: (2019-06-01) -
TBLR1 regulates the expression of nuclear hormone receptor co-repressors
by: Brown Stuart, et al.
Published: (2006-08-01) -
The nuclear pore complex mediates binding of the Mig1 repressor to target promoters.
by: Nayan J Sarma, et al.
Published: (2011-01-01) -
TIP30 counteracts cardiac hypertrophy and failure by inhibiting translational elongation
by: Andrea Grund, et al.
Published: (2019-10-01)